Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedOct 10, 2025
DataAggregated Company Financials
Companies208
  • 7D1.6%
  • 3M4.2%
  • 1Y3.6%
  • YTD7.0%

The market has climbed 1.6% in the last 7 days, lead by the Healthcare sector with a gain of 2.9%. In the last year, the market has climbed 3.6%. Earnings are forecast to grow by 11% annually.

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 10 Oct 2025CHF 1.9tCHF 777.3bCHF 90.7b19.7x21x2.5x
Sun, 07 Sep 2025CHF 1.9tCHF 774.7bCHF 90.1b19.5x20.8x2.4x
Tue, 05 Aug 2025CHF 1.8tCHF 775.5bCHF 89.9b20.6x20.2x2.3x
Thu, 03 Jul 2025CHF 1.8tCHF 783.1bCHF 106.5b20.2x17x2.3x
Sat, 31 May 2025CHF 1.8tCHF 785.7bCHF 106.4b20.1x17.2x2.3x
Mon, 28 Apr 2025CHF 1.8tCHF 837.2bCHF 157.2b19x11.2x2.1x
Wed, 26 Mar 2025CHF 1.9tCHF 849.9bCHF 158.9b20.1x12x2.2x
Fri, 21 Feb 2025CHF 1.9tCHF 820.1bCHF 116.5b21.5x16.3x2.3x
Sun, 19 Jan 2025CHF 1.8tCHF 819.7bCHF 118.0b21.1x15.2x2.2x
Tue, 17 Dec 2024CHF 1.7tCHF 813.5bCHF 117.3b20.5x14.9x2.1x
Thu, 14 Nov 2024CHF 1.7tCHF 815.8bCHF 117.6b19.8x14.8x2.1x
Sat, 12 Oct 2024CHF 1.8tCHF 803.6bCHF 114.1b21.5x16x2.3x
Mon, 09 Sep 2024CHF 1.8tCHF 799.7bCHF 113.5b21.1x15.7x2.2x
Wed, 07 Aug 2024CHF 1.7tCHF 796.6bCHF 135.5b21.5x12.8x2.2x
Fri, 05 Jul 2024CHF 1.8tCHF 802.6bCHF 125.8b21.5x14.4x2.3x
Sun, 02 Jun 2024CHF 1.8tCHF 803.7bCHF 126.0b22x14.3x2.2x
Tue, 30 Apr 2024CHF 1.7tCHF 799.2bCHF 125.4b21.5x13.7x2.2x
Thu, 28 Mar 2024CHF 1.8tCHF 768.3bCHF 98.5b21.7x18.1x2.3x
Sat, 24 Feb 2024CHF 1.7tCHF 766.1bCHF 111.1b20.3x15.6x2.3x
Mon, 22 Jan 2024CHF 1.7tCHF 766.5bCHF 110.4b18x15.1x2.2x
Wed, 20 Dec 2023CHF 1.7tCHF 764.9bCHF 110.1b18.5x15.3x2.2x
Fri, 17 Nov 2023CHF 1.6tCHF 773.0bCHF 111.5b17.7x14.5x2.1x
Sun, 15 Oct 2023CHF 1.6tCHF 761.3bCHF 100.3b18.1x16.3x2.1x
Tue, 12 Sep 2023CHF 1.7tCHF 750.2bCHF 99.2b18.5x16.8x2.2x
Thu, 10 Aug 2023CHF 1.7tCHF 743.3bCHF 75.3b18.9x22.2x2.3x
Sat, 08 Jul 2023CHF 1.7tCHF 755.6bCHF 76.7b18.9x21.8x2.2x
Mon, 05 Jun 2023CHF 1.8tCHF 788.4bCHF 82.8b18.8x21.2x2.2x
Wed, 03 May 2023CHF 1.8tCHF 785.5bCHF 80.8b19.3x21.8x2.2x
Fri, 31 Mar 2023CHF 1.7tCHF 780.6bCHF 69.3b19.7x24.9x2.2x
Sun, 26 Feb 2023CHF 1.7tCHF 783.7bCHF 71.4b18.9x24.1x2.2x
Tue, 24 Jan 2023CHF 1.8tCHF 787.0bCHF 94.1b17.8x19x2.3x
Thu, 22 Dec 2022CHF 1.7tCHF 787.3bCHF 94.0b17.3x17.9x2.1x
Sat, 19 Nov 2022CHF 1.7tCHF 792.5bCHF 95.5b17.6x17.9x2.2x
Mon, 17 Oct 2022CHF 1.6tCHF 801.9bCHF 103.8b16.5x15.5x2x
Price to Earnings Ratio

15.5x


Total Market Cap: CHF 1.6tTotal Earnings: CHF 103.8bTotal Revenue: CHF 801.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 17.4x202320242025
Current Market PE
  • Investors are optimistic on the Swiss market, and appear confident in strong long term growth rates.
  • The market is trading at a PE ratio of 21.0x which is higher than its 3-year average PE of 17.4x.
Past Earnings Growth
  • The earnings for Swiss listed companies have declined 4.4% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market1.61%
Healthcare2.89%
Utilities2.85%
Financials1.47%
Telecom1.35%
Consumer Staples1.19%
Consumer Discretionary1.07%
Industrials0.54%
Materials0.32%
Tech0.27%
Real Estate-0.53%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading above its 3-year average PE ratio of 8.8x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 26.9% which is higher than its past year's earnings decline of 1.3% per year.
  • The Financials sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 9.9x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 27% over the next 5 years.
  • This is better than its past earnings decline of 1.3% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 8.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
ROG Roche HoldingCHF 293.603.3%
+CHF 7.9b		10.3%PE26.5xHealthcare
NOVN NovartisCHF 106.622.5%
+CHF 5.0b		8.1%PE18.7xHealthcare
GALD Galderma GroupCHF 147.106.7%
+CHF 2.2b		85.0%PE114.5xHealthcare
LISN Chocoladefabriken Lindt & SprüngliCHF 126.80k5.7%
+CHF 1.6b		19.2%PE45.4xConsumer Staples
SDZ Sandoz GroupCHF 49.497.8%
+CHF 1.5b		30.5%PE116.4xHealthcare
See more

Market Insights

Header cover image
📈 Markets Break Records: Q3 2025 in Review, Q4 Outlook Ahead
Richard Bowman avatar
Richard Bowman
|
|
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
✨Rare Earths: Tiny Market, Outsized Influence
Last Week

✨Rare Earths: Tiny Market, Outsized Influence

Latest News

GF
CHF 61.10
Georg Fischer
7D
-4.2%
1Y
3.6%
KNIN
CHF 150.85
Kuehne + Nagel International
7D
-1.1%
1Y
-31.8%

We Think Kuehne + Nagel International (VTX:KNIN) Can Stay On Top Of Its Debt

Oct 09
We Think Kuehne + Nagel International (VTX:KNIN) Can Stay On Top Of Its Debt
BEAN
CHF 800.00
BELIMO Holding
7D
-3.2%
1Y
37.2%

Does BELIMO Holding (VTX:BEAN) Deserve A Spot On Your Watchlist?

Oct 09
Does BELIMO Holding (VTX:BEAN) Deserve A Spot On Your Watchlist?
ARYN
CHF 52.60
ARYZTA
7D
-17.0%
1Y
-19.1%
SREN
CHF 151.70
Swiss Re
7D
3.2%
1Y
31.2%

Expanding Natural Catastrophe Risks And Urbanization Will Reshape Reinsurance Prospects

Analysts have reduced their fair value estimate for Swiss Re slightly, from CHF 140.27 to CHF 141.76. They cite a softer reinsurance market outlook and valuation pressures as key factors behind the change.
ROG
CHF 293.60
Roche Holding
7D
3.3%
1Y
10.3%
GIVN
CHF 3,377.00
Givaudan
7D
4.4%
1Y
-23.9%

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Givaudan's analyst price target has been revised downward from CHF 4,081.95 to CHF 3,996.53, reflecting slightly lower revenue growth expectations and profit margin forecasts according to recent analyst updates. Analyst Commentary Recent analyst activity on Givaudan has resulted in a mix of revised targets and sentiment shifts that reflect both optimism around the company's strengths and caution regarding its outlook in the current market environment.
SIKA
CHF 173.25
Sika
7D
-2.8%
1Y
-32.3%

Is It Time To Consider Buying Sika AG (VTX:SIKA)?

Oct 07
Is It Time To Consider Buying Sika AG (VTX:SIKA)?
NOVN
CHF 106.62
Novartis
7D
2.5%
1Y
8.1%

China Expansion And Advanced Therapies Will Drive Future Upside

Analysts have raised their fair value estimate for Novartis from $97.49 to $99.08. They cite improved revenue growth projections, even though profit margin expectations have decreased slightly.
LISN
CHF 126,800.00
Chocoladefabriken Lindt & Sprüngli
7D
5.7%
1Y
19.2%
LOGN
CHF 88.16
Logitech International
7D
-1.9%
1Y
20.8%
UBSG
CHF 32.35
UBS Group
7D
1.0%
1Y
19.7%

Global Banking Integration And Digital Transformation Will Improve Efficiency

Analysts have raised their price targets for UBS Group to CHF32.69, citing improving long-term earnings prospects and the view that integration risks and macro headwinds are already reflected in the share price, with the stock expected to remain range-bound ahead of Q4 results. Analyst Commentary Bullish analysts cite expanding earnings potential for UBS through 2028 as a driver for higher price targets.
SDZ
CHF 49.49
Sandoz Group
7D
7.8%
1Y
30.5%
GALD
CHF 147.10
Galderma Group
7D
6.7%
1Y
85.0%
HOLN
CHF 66.48
Holcim
7D
-0.8%
1Y
-20.1%

Aggressive Projections Will Falter Amid Regulatory And Market Risks

Analysts increased Holcim’s target price to CHF68.35, citing resilient earnings, long-term growth from decarbonization, and value realization post-North America spin-off, despite concerns over full near-term valuation and earnings risks. Analyst Commentary Bullish analysts cited Holcim's resilient heavy side business performance and stable earnings outlook, even amid soft U.S. construction trends.
EMSN
CHF 561.50
EMS-CHEMIE HOLDING
7D
-1.7%
1Y
-17.5%